Global post-op shoe market projected to reach $1.1 bn by 2031

The global post-op shoe market is on a steady growth trajectory, with its valuation projected to rise from $634.50 million in 2021 to $1.1 billion by 2031, registering a compound annual growth rate (CAGR) of 5.1 per cent throughout the forecast period.

According to a new report published by Allied Market Research, titled "Post-Op Shoe Market," these specialized medical shoes—typically utilized by patients undergoing surgery or recovering from foot and ankle injuries—maintain their strongest presence in Europe and North America, closely followed by the Asia-Pacific region. Commercial examples of these products driving the sector include the adjustable Darco med post-op surg shoe, Darco slimline cast boot, EZ Walking foot and ankle support cast boot, canvas rocker bottom cast shoe, and pediatric classic post op shoe with buckle closure.

The global market is segmented by type (rigid sole, soft sole, and semi-rigid sole), end user (adult and children), distribution channel (medical & pharma store, specialty store, and online retail), and region (North America, Europe, Asia-Pacific, and LAMEA).

Analysis by product type reveals that the semi-rigid post-op shoe segment, which was valued at $298.1 million in 2021, is expected to hit $492.7 million by 2031, expanding at a CAGR of 5.2%. This growth is primarily attributed to a broadening variety of product offerings, emerging as a major trend boosting overall market demand.

In terms of end users, the adult segment accounts for the largest share of revenue and is expected to sustain a CAGR of 5.2% during the forecast period. This dominance is driven by an increasing incidence of foot and ankle injuries among adults. Looking at distribution channels, medical and pharma stores represented the largest channel, valued at $266.0 million in 2021, and are forecast to reach $438.1 million by 2031 at a CAGR of 5.1%. The consistent product availability in traditional medical and pharmaceutical retail remains a critical factor expanding this market share.

Geographically, North America holds the largest share of the global post-op shoe market and is projected to maintain its leading position through 2031, largely supported by rapid technological developments aimed at enhancing product performance. However, the Asia-Pacific region is predicted to experience the most promising growth rate, driven by ongoing regional development and lucrative commercial offerings.

The industry is also navigating the trailing effects of the COVID-19 pandemic, which inflicted a negative impact on the market. Manufacturers and exporters faced fierce international competition amidst severe supply chain disruptions, border closures, and heightened trade barriers. Furthermore, subsequent lockdowns and the temporary closure of physical retail establishments caused a decline in on-premise sales. Conversely, accelerated sales via online retail channels significantly aided market penetration during this disruptive period.

To secure market share, prominent industry players are prioritizing product innovation, new product launches, and geographic expansion to deliver more advanced options to consumers. The leading entities operating in the global post-op shoe industry include A. Algeo Ltd., Bird and Cronin, LLC., Breg, Inc, DJO, LLC, DoctorschoiceDME., Henry Schein, Inc., Össur, Safte S.p.A., and Steeper Inc.